Clinical Trials
Lilly and Incyte announce results from the Phase 3...
Eli Lilly and Company and Incyte announced results of COV-BARRIER, a Phase 3 study evaluating baricitinib 4 mg once daily plus standard of care (SoC)...
Packaging & Labelling
FedEx Distribution of COVID-19 Vaccines Grows, Reaches 100 Million...
For more than a year, FedEx has been on the frontlines of the COVID-19 pandemic, delivering pharmaceuticals, personal protective equipment, critical medical supplies and e-commerce...
Clinical Trials
Moleculin Engages IQVIA to Manage Potential COVID-19 Clinical Trial
Moleculin Biotech, Inc., a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses, announced the engagement of...
Drug Research
Moderna and Catalent Announce Long-Term Strategic Collaboration for Dedicated...
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Catalent, Inc., the leading global provider of advanced delivery technologies, development, and...
Packaging & Labelling
Moderna Announces Shipment of 100 Millionth Dose of its...
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that the Company has shipped the 100-millionth dose of its COVID-19 vaccine...
Press Releases
Celonic and CureVac Announce Agreement to Manufacture over 100...
CureVac N.V., a biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) and Celonic Group, a premium biopharmaceutical Contract...
Clinical Trials
Lilly, Vir And GSK Report Positive Topline Data From...
Eli Lilly and Company, Vir Biotechnology, Inc. and GlaxoSmithKline plc announced topline data from the expanded Phase 2 BLAZE-4 trial studying low-risk adult patients with...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.